Articles by Moe Alsumidaie - Applied Clinical Trials

ADVERTISEMENT

Articles by Moe Alsumidaie

Moe Alsumidaie


Articles
Why Pfizer is Hungry for Acquisition
October 24, 2014

Is Pfizer prime for acquiring another biopharmaceutical company?

Where Should Investigators New to Clinical Research Start?
October 21, 2014

There are a number of indicators that suggest that US clinical trial growth is far from plateauing, and demand for clinical research investigators will continue to rise with this growing trend.

Conquering RBM: A Story on Medtronic's Risk Based Management Methodology
October 14, 2014

The industry has tried to establish some consistency by standardizing RBM methodologies.

Highlights from the 2014 ePatient Connections Summit
September 29, 2014

Two main themes arose from the ePatient Connections Summit: online patient engagement and patient centricity.

Eli Lilly Unveils Innovative Study Design Platform
September 24, 2014

Thomas Krohn, Director of Clinical Open Innovation at Eli Lilly, showcased a breakthrough study design platform and process that study teams are currently utilizing.

Highlights from the 2014 Patient Centered Clinical Trials Symposium
September 9, 2014

Eye for Pharma hosted its first Patient Centered Clinical Trials symposium in Boston.

Aggregated EMR: How Study Sites Can Develop a Collaborative Subject Enrollment Infrastructure
August 28, 2014

In this Electronic Medical Records blog series, we explained the basics of Aggregated EMR.

Aggregated EMR: Mitigating Trial Risk through Quality by Design Protocols
August 27, 2014

Cultural factors embedded in clinical operations groups, such as focusing on First Patient in deadlines takes away from the quality of a robustly designed protocol.

Medical Marijuana Clinical Trials: Preempted by Politics
August 14, 2014

There has been a lot of debate on the therapeutic use of marijuana.

Advertisement

ADVERTISEMENT

Untitled Document
Click here